SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences gains on the BSE

17 Jan 2020 Evaluate

Camlin Fine Sciences is currently trading at Rs. 80.35, up by 1.35 points or 1.71% from its previous closing of Rs. 79.00 on the BSE.

The scrip opened at Rs. 76.00 and has touched a high and low of Rs. 81.50 and Rs. 76.00 respectively. So far 38810 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 89.90 on 02-Jan-2020 and a 52 week low of Rs. 38.80 on 16-May-2019.

Last one week high and low of the scrip stood at Rs. 85.85 and Rs. 76.00 respectively. The current market cap of the company is Rs. 957.91 crore.

The promoters holding in the company stood at 22.74%, while Institutions and Non-Institutions held 22.30% and 54.97% respectively.

Camlin Fine Sciences has received Closure Direction dated January 15, 2020 from the Regional Officer, Maharashtra Pollution Control Board (MPCB) for closure of the company's manufacturing unit situated at Plot D- 2/3, MIDC, Tarapur, District Palghar, within 72 hours from receipt of the aforementioned directions. These directions are issued on account of certain alleged irregularities by the company in complying with MPCB's terms and conditions.

The company has initiated necessary steps with the concerned authorities to resolve the matter. The impact of the said directions are contingent upon the outcome of company's representations before the concerned authorities.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

133.70 3.05 (2.33%)
06-May-2026 14:27 View Price Chart
Peers
Company Name CMP
BASF India 3770.45
Tata Chemicals 815.90
SRF 2721.90
Pidilite Inds. 1424.60
Deepak Nitrite 1832.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×